Atostatin 10 mg (Atorvastatin Calcium Trihydrate)

Adult dose

In the treatment of hyperlipidemia, the recommended initial dose is 10 mg once daily; for patients needing more significant reductions in LDL cholesterol, dosing can be initiated at 20 mg or 40 mg once daily. The dose is adjusted within a range of 10 to 80 mg once daily, individualized based on treatment goals and patient response. Lipid levels should be analyzed within 2 to 4 weeks after the initiation of therapy to adjust the dosage accordingly.

Child dose

For pediatric patients (ages 10 to 17 years) with heterozygous familial hypercholesterolemia, the recommended initial dose is 10 mg once daily, and the maximum dose is 20 mg once daily. Adjustments to dosing should be made every 4 weeks or more as per treatment goals.

This medication may cause unusual symptoms in muscles, so if severe muscle pain or weakness occurs, or if creatine kinase levels are significantly elevated, the use of this medication should be discontinued immediately. This drug should not be used in patients with certain liver or muscle diseases, women who are pregnant or could become pregnant, children under 10 years of age, and patients taking specific medications. Patients with liver or kidney function problems should be particularly cautious when taking this medication and should monitor liver function and muscle condition regularly. Side effects such as muscle pain, fatigue, malaise, indigestion, headache, and insomnia may occur while taking this medication, so if these symptoms are severe or persistent, consultation with a physician is necessary. Additionally, this medication has a high potential for interactions with other drugs, so if other medications are being taken, it is essential to inform a healthcare provider and not to discontinue or change medication regimens arbitrarily. This medication is contraindicated during pregnancy, and women of childbearing potential should use appropriate contraception while taking it, discontinuing use immediately if pregnancy is confirmed. Lactating women should not take this medication and should either discontinue breastfeeding or consult a healthcare provider. Elderly patients or those with kidney impairment have a higher risk of muscle disease and rhabdomyolysis, so caution is advised, and regular health assessments are recommended. There is no specific antidote for overdose, so treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored periodically. Keep out of reach of children and store the medication in its original container to maintain quality.

Serious side effects

Urticaria, angioedema, chest tightness, difficulty breathing, cold sweats, pallor, severe allergic reactions, severe rashes, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, severe dermatological reactions, difficulty breathing, asthma attacks, respiratory irregularities with cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, liver issues (jaundice), sudden and very severe headaches, thunderclap headaches.

Mild side effects

• Weakness
• malaise
• chest pain
• peripheral edema
• fatigue
• fever
• pharyngitis
• hyperglycemia
• hypoglycemia
• weight gain

This medication should be stored in a tightly closed container to prevent air or moisture from entering. Ideally, maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

White oval-shaped film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle